To our knowledge, the existed off-table immunosuppress-targeting drugs is mainly focusing on the IFN-γ-JAK-chemokines signaling pathway, which exhibit the moderate effects in vitiligo therapy (Frisoli and Harris, 2017). Here, IFNG is linked to vitiligo.